News

Please check back frequently for important and
exciting updates as they become available! 

Diabetic Ulcer Trial Results with Photos

Argyll Biotech releases First Phase "Proof of Concept Trial" results for treatment of Diabetic Ulcers from SF-1019 with wound healing photographs. Click here to view the document.

Exclusive License Agreement to Immunosyn
Argyll Biotechnologies has transferred to Immunosyn Corporation the world-wide rights to market and distribute SF-1019 by way of an exclusive licensing agreement. Additional information on this subject will follow shortly.